Long-Term Assets: The sum of all assets classified as non-current.
Fulgent Genetics, Inc. (FLGT) had Long-Term Assets of $866.39M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
$283.47M |
|
$-42.71M |
|
$176.25M |
|
$107.22M |
|
$357.39M |
|
$-73.92M |
|
$21.96M |
|
$-51.96M |
|
$-41.88M |
|
$-43.82M |
|
$-43.82M |
|
$-43.82M |
|
$-32.17M |
|
$-73.92M |
|
$-54.54M |
|
30.23M |
|
30.23M |
|
$-1.41 |
|
$-1.41 |
|
Balance Sheet Financials | |
$353.57M |
|
$105.55M |
|
Long-Term Assets |
$866.39M |
$1.22B |
|
$72.90M |
|
-- |
|
$17.91M |
|
$90.81M |
|
$1.13B |
|
$972.13M |
|
$1.13B |
|
30.84M |
|
Cash Flow Statement Financials | |
$21.06M |
|
$-58.35M |
|
$-4.85M |
|
$97.47M |
|
$55.28M |
|
$-42.19M |
|
$44.48M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.85 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
37.82% |
|
-26.08% |
|
-26.08% |
|
-19.24% |
|
-18.33% |
|
-15.07% |
|
$-18.94M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
-- |
|
4.11 |
|
88.87 |
|
-3.88% |
|
-4.51% |
|
-3.59% |
|
-3.88% |
|
$36.61 |
|
$-0.63 |
|
$0.70 |